Chapter 53 ITG human myelopoietin price? !
"The First People's Hospital of Jiangsu Province, 25,000 boxes, totaling 12 million yuan."
"Ruijin Hospital, Jiaotong University, Shanghai, 30,000 boxes, totaling 14.4 million yuan."
"West China Hospital of Sichuan Province...50,000 boxes, totaling 24 million yuan!"
"..."
"Zhang Yang, I have to say that these big hospitals are really rich. They bought tens of millions of dollars at a time."
Looking at the purchase order in his hand, Ren Xiaomin was filled with emotion.
In the past few months, he visited all the major tertiary hospitals in the surrounding area, and the amount of hospital purchases he finally negotiated was not even as good as that of West China Hospital.
Zhang Yang didn't have any feelings at all. The current medical situation in China was like this. The size of top hospitals like West China was simply not comparable to that of ordinary top-level hospitals.
“By the way, have they agreed to our payment method?”
"Agreed, they were very happy."
Ren Xiaomin smiled and nodded.
According to the conventions of the pharmaceutical industry, it takes at least half a year for pharmaceutical companies to supply hospitals before they can get the payment, but this time Zhang Yang directly asked the hospital to pay at least 50% first, and then pay the rest three months later. of the final payment.
Zhang Yang also showed a smile. He knew very well that the reason why the hospital was so happy was not because of "ITG human myelopoietin."
“Okay, Brother Ren, I’ll leave the rest to you.”
"However, although we are in a proactive position now, with the entry of 'Qingshan Awa' into the hospital, the annual purchase volume is expected to be large, and we still need to maintain a good relationship with them."
"You Don’t worry, I know!”
“Yeah!”
After solving the problem of “Qingshan Avatrombopag” entering the hospital, Qingshan Pharmaceutical’s current dilemma has been perfectly solved.
The next day, as several hospitals received tens of millions of dollars in drug purchase funds, Zhang Yang’s mind fell on the hepatitis B drug "Acofenprovir".
The clinical trial of "Icofenprofovir" was temporarily put on hold. On the one hand, it was because it was too close to "ITG generating hormone". The sudden introduction of a new drug was too abrupt and difficult to explain.
On the other hand, it was also because Tsingshan Pharmaceutical had tight funds in its accounts at that time, and it required money to expand its R&D personnel and the third phase of the "ITG" clinical trial.
Now at least the funding problem is solved.
But...
After thinking for a long time, Zhang Yang still didn’t think of a more appropriate way to start the clinical trial of "Acofenprofovir",
Last time, "ITG human myelopoietin" was used as an adjuvant treatment and converted into a first-line drug. It must not be used again this time.
After much thought, the only way is to wait!
"Hey! We can only wait a little longer until 'ITG Myelopoietin' is on the market for a while!"
Having made up his mind, Zhang Yang felt a little helpless,
I had no choice but to put aside the matter of "Acofenprovir" and start preparing for the launch of "ITG Human Myelopoietin"!
One month later, the last group of the "ITG human myelopoietin" clinical phase III completed the clinical trial, which also means that the "ITG human myelopoietin" clinical phase III is complete!
The clinical data this time is no different from the previous group. All the patients who entered the "test group" had bone penetration results that were completely cured, while those in the control group were completely cured despite taking "Avatrex". The blood picture was good despite the "Popa tablet", but the bone biopsy results still showed "aplastic anemia".
550 complete pieces of data were quickly submitted to the State Food and Drug Administration. Because "ITG" is a blood disease treatment drug like the original "Qingshan Ava", the approval process still followed the green channel specially opened by the country. .
In just one and a half months, "ITG Human Myelopoietin" passed the Phase III clinical trial without any controversy due to its excellent therapeutic effect. Zhang Yang immediately started applying for drug production approval without stopping.
"ITG human myelopoietin" still chose Hehua Pharmaceutical, which has been OEM for "Qingshan Afa", for OEM production.
But this time, the production of "ITG" was significantly more difficult and the requirements were stricter. It took Hehua Pharmaceutical more than a month of improvement to meet various production indicators and reach drug production standards.
One week later,
the drug production approval document was successfully passed, and the relevant parameter information of Tsingshan Pharmaceutical's "ITG Human Myelopoietin" appeared on the official website of the State Food and Drug Administration for the first time!
At this point,
All procedures before the launch of "ITG" have been completed, which also means that "ITG myelopoietin", which can completely cure "aplastic anemia", has entered the countdown to launch!
Countless patients who are paying attention to "ITG Generating Hormone" cheer for joy, they have finally waited for this day!
And those patients who came here because of the reputation, waited for a long time, or even delayed the "bone marrow transplant" excitedly rushed to the website of the General Administration of Food and Drug Administration to check out the relevant information about "ITG human myelopoietin" in advance.
Huaxia Medical News quickly noticed this and immediately published all the data and information on Qingshan Pharmaceutical’s “ITG Human Myelopoietin” into an article and posted it on the public account.
“Quick, Huaxia Medicine’s official account has posted an article about ‘ITG Generator’. Let’s take a look at what it looks like and how to use it!”
After a while, many patients in the group opened the official account articles and started reading.
【Different from the previous "Qingshan Avatrombopag", "ITG Generator" is an injection preparation, a colorless and clear liquid, mainly intravenous injection. 】
【At the same time, because the main component is active recombinant biotin, it needs to be refrigerated at low temperature. The activity of the drug will be reduced and the efficacy will be lost within two hours at room temperature. 】
Seeing this, everyone didn’t care because “ITG” is an injection preparation.
After all, almost every aplastic patient is a frequent visitor to the hospital, so it is normal to go to the hospital for injections and treatment.
Soon, everyone saw the information on dosage and medication cycle.
【ITG treatment cycle is three months in total, twelve weeks. 】
【After patients start receiving ITG treatment, they only need to inject the drug once a week for twelve consecutive weeks. 】
[According to clinical trial data statistics, after eight weeks of continuous treatment for "common aplastic anemia patients", 86% of patients were cured, and the remaining 14% of patients achieved complete recovery by the tenth week. cure. 】
[After ten weeks of continuous treatment for "super-severe aplastic patients", 78% of the patients were cured, and the remaining 22% of the patients were completely cured after twelve weeks. 】
[Special note: 0.2% of patients are not completely cured after twelve weeks. This situation requires another consolidation cycle. 】
Although many patients have already known that the cure rate of "ITG" is almost 100% through previous clinical trial subjects, they were really relieved when they saw the official information with their own eyes.
One shot per week can be completely cured in just two or three months. This method is completely acceptable!
Everyone continued to watch and soon saw the adverse reactions.
[Common adverse reactions during treatment with this product include: nausea, vomiting, diarrhea, loss of appetite, drowsiness...]
[Rare adverse reactions during the treatment of this product include: hair loss, insomnia, irritability, anxiety, etc...]
At the end, everyone was finally relieved and had a better understanding of "ITG Human Myelopoietin" A clear understanding...
But gradually, as the excitement passed, everyone began to feel more and more nervous.
According to "ITG"'s own instructions, most patients can actually achieve complete cure with eight injections in two months. So how much does this injection preparation cost? !
Conjectures and discussions about the price of "ITG" gradually appeared in major patient groups.
(End of this chapter)